Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy

2004 ◽  
Vol 262 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Haralampos Gouveris ◽  
Oksana Selivanova ◽  
Wolf Mann
Author(s):  
K. Mallikarjuna Swamy ◽  
Arati Ganiger

<p class="abstract"><strong>Background:</strong> The aim of this study is to assess the effect of intratympanic dexamethasone injection (ITDI) in patients with idiopathic sudden sensorineural hearing loss (ISSNHL).</p><p><strong>Methods:</strong> A prospective study was conducted on 40 patients refractory to intravenous steroid therapy between May 2012 to March 2014. Intratympanic dexamethasone injection was given every week for 3 consecutive weeks. Hearing was assessed by performing pure tone audiogram before every ITDI and also 1 week after the completion of treatment.</p><p><strong>Results: </strong>Hearing improvement was seen in 27 out of the 40 cases (68%).<strong></strong></p><p class="abstract"><strong>Conclusions:</strong> Intratympanic dexamethasone significantly improves the prognosis of ISSNHL and is a safe, inexpensive and effective treatment in ISSNHL.</p>


2015 ◽  
Vol 36 (8) ◽  
pp. 1321-1327 ◽  
Author(s):  
Thomas H. Alexander ◽  
Jeffrey P. Harris ◽  
Quyen T. Nguyen ◽  
Nopawan Vorasubin

Sign in / Sign up

Export Citation Format

Share Document